BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: You X, Zhang R, Shao M, He J, Chen J, Liu J, Zhang X, Liu X, Jia R, Sun X, Li Z. Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission. Front Med (Lausanne) 2020;7:85. [PMID: 32318574 DOI: 10.3389/fmed.2020.00085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Mauro D, Manou-stathopoulou S, Rivellese F, Sciacca E, Goldmann K, Tsang V, Lucey-clayton I, Pagani S, Alam F, Pyne D, Rajakariar R, Gordon PA, Whiteford J, Bombardieri M, Pitzalis C, Lewis MJ. UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus. Journal of Autoimmunity 2023;136:103023. [DOI: 10.1016/j.jaut.2023.103023] [Reference Citation Analysis]
2 Beckers L, Somers V, Fraussen J. IgD(-)CD27(-) double negative (DN) B cells: Origins and functions in health and disease. Immunol Lett 2023;255:67-76. [PMID: 36906182 DOI: 10.1016/j.imlet.2023.03.003] [Reference Citation Analysis]
3 Looney CM, Schroeder A, Tavares E, Garg J, Schindler T, Vincenti F, Redfield RR, Jordan SC, Busque S, Woodle ES, Khan J, Eastham J, Micallef S, Austin CD, Morimoto A. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Transplant Direct 2023;9:e1436. [PMID: 36700064 DOI: 10.1097/TXD.0000000000001436] [Reference Citation Analysis]
4 Nasrollahi H, Talepoor AG, Saleh Z, Eshkevar Vakili M, Heydarinezhad P, Karami N, Noroozi M, Meri S, Kalantar K. Immune responses in mildly versus critically ill COVID-19 patients. Front Immunol 2023;14:1077236. [PMID: 36793739 DOI: 10.3389/fimmu.2023.1077236] [Reference Citation Analysis]
5 Hirano A, Fujioka K, Kida T, Omura S, Sofue H, Sakashita A, Sagawa T, Isoda Y, Kasahara A, Sagawa R, Fujii W, Seno T, Wada M, Kohno M, Kawahito Y. Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus. Lupus 2023;32:63-73. [PMID: 36317306 DOI: 10.1177/09612033221137249] [Reference Citation Analysis]
6 Md Yusof MY, Alivernini S, Chatzidionysiou K. Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1020859] [Reference Citation Analysis]
7 Maamari KA, Busaidi IA, Kindi MA, Zadjali F, BaAlawi F, Anesta W, Amri KA, Albalushi W, Balushi HA, Amri AA, Aljufaili M, Al-Busaidi M, Muharrmi ZA, Balkhair A, Riyami NA, Ghanim Z, Alshekaili J. Short and long-term immune changes in different severity groups of COVID-19 disease. Int J Infect Dis 2022;122:776-84. [PMID: 35840099 DOI: 10.1016/j.ijid.2022.07.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kajihara A, Morita T, Kato Y, Konaka H, Murakami T, Yamaguchi Y, Koyama S, Takamatsu H, Nishide M, Maeda Y, Watanabe A, Nishida S, Hirano T, Shima Y, Narazaki M, Kumanogoh A. The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus. Int Immunol 2023;35:27-41. [PMID: 35997780 DOI: 10.1093/intimm/dxac042] [Reference Citation Analysis]
9 Sosa-Hernández VA, Romero-Ramírez S, Cervantes-Díaz R, Carrillo-Vázquez DA, Navarro-Hernandez IC, Whittall-García LP, Absalón-Aguilar A, Vargas-Castro AS, Reyes-Huerta RF, Juárez-Vega G, Meza-Sánchez DE, Ortiz-Navarrete V, Torres-Ruiz J, Mejía-Domínguez NR, Gómez-Martín D, Maravillas-Montero JL. CD11c+ T-bet+ CD21hi B Cells Are Negatively Associated With Renal Impairment in Systemic Lupus Erythematosus and Act as a Marker for Nephritis Remission. Front Immunol 2022;13:892241. [PMID: 35663936 DOI: 10.3389/fimmu.2022.892241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Levack RC, Newell KL, Cabrera-Martinez B, Cox J, Perl A, Bastacky SI, Winslow GM. Adenosine receptor 2a agonists target mouse CD11c+T-bet+ B cells in infection and autoimmunity. Nat Commun 2022;13:452. [PMID: 35064115 DOI: 10.1038/s41467-022-28086-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 He Y, Gallman AE, Xie C, Shen Q, Ma J, Wolfreys FD, Sandy M, Arsov T, Wu X, Qin Y, Zhang P, Jiang S, Stanley M, Wu P, Tan J, Ding H, Xue H, Chen W, Xu J, Criswell LA, Nititham J, Adamski M, Kitching AR, Cook MC, Cao L, Shen N, Cyster JG, Vinuesa CG. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med 2022;219:e20211004. [PMID: 34889940 DOI: 10.1084/jem.20211004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
12 Yu L, Chen Y, Xu X, Dong Q, Xiu W, Chen Q, Wang J, He C, Ye J, Lu F. Alterations in Peripheral B Cell Subsets Correlate with the Disease Severity of Human Glaucoma. J Inflamm Res 2021;14:4827-38. [PMID: 34584441 DOI: 10.2147/JIR.S329084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gong L, Kwong DL, Dai W, Wu P, Wang Y, Lee AW, Guan XY. The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment. Front Oncol 2021;11:744889. [PMID: 34568077 DOI: 10.3389/fonc.2021.744889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wei Y, Chen X, Zhang H, Su Q, Peng Y, Fu Q, Li J, Gao Y, Li X, Yang S, Ye Q, Huang H, Deng R, Li G, Xu B, Wu C, Wang J, Zhang X, Su X, Liu L, Xiang AP, Wang C. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study. Front Immunol 2021;12:662441. [PMID: 34248942 DOI: 10.3389/fimmu.2021.662441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li Y, Li Z, Hu F. Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity. Clin Exp Immunol 2021;205:119-27. [PMID: 33969476 DOI: 10.1111/cei.13615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
16 Stewart A, Ng JC, Wallis G, Tsioligka V, Fraternali F, Dunn-Walters DK. Single-Cell Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways. Front Immunol 2021;12:602539. [PMID: 33815362 DOI: 10.3389/fimmu.2021.602539] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
17 Rincon-Arevalo H, Wiedemann A, Stefanski AL, Lettau M, Szelinski F, Fuchs S, Frei AP, Steinberg M, Kam-Thong T, Hatje K, Keller B, Warnatz K, Radbruch A, Lino AC, Schrezenmeier E, Dörner T. Deep Phenotyping of CD11c+ B Cells in Systemic Autoimmunity and Controls. Front Immunol 2021;12:635615. [PMID: 33777025 DOI: 10.3389/fimmu.2021.635615] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
18 Taefehshokr N, Taefehshokr S, Heit B. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2. Pathogens 2020;9:E1027. [PMID: 33302366 DOI: 10.3390/pathogens9121027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
19 Stewart A, Ng J, Wallis G, Tsioligka V, Fraternali F, Dunn-walters D. Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways.. [DOI: 10.1101/2020.09.03.281527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]